$800 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 67 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 37.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS | $41,023,000 | +12.7% | 2,850,769 | +18.1% | 5.13% | +9.4% |
| APLS | New | APELLIS PHARMACEUTIC | $38,033,000 | – | 1,752,655 | +100.0% | 4.75% | – |
| ACAD | Buy | ACADIA PHARMACEUTICALS | $34,076,000 | +10.0% | 1,131,722 | +37.6% | 4.26% | +6.7% |
| NVS | Sell | NOVARTIS AGspns ad | $31,527,000 | -4.3% | 375,496 | -2.2% | 3.94% | -7.2% |
| PFE | Sell | PFIZER INC | $31,514,000 | -7.8% | 870,074 | -9.1% | 3.94% | -10.6% |
| XLRN | Buy | ACCELERON PHARMA | $30,232,000 | +33.9% | 712,356 | +17.8% | 3.78% | +29.9% |
| JNJ | Sell | JOHNSON & JOHNSON | $29,949,000 | -2.1% | 214,349 | -8.9% | 3.74% | -5.0% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL | $27,491,000 | +31.4% | 854,301 | +42.0% | 3.44% | +27.5% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL | $26,340,000 | +43.5% | 1,426,862 | -18.4% | 3.29% | +39.2% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $26,113,000 | -4.6% | 536,414 | +5.9% | 3.26% | -7.4% |
| CELG | Buy | CELGENE CORP | $24,194,000 | +28.7% | 231,830 | +79.8% | 3.02% | +24.8% |
| TDOC | Sell | TELADOC INC | $23,755,000 | -2.3% | 681,628 | -7.1% | 2.97% | -5.2% |
| BMRN | Buy | BIOMARIN PHARMAC INC | $23,051,000 | +3.9% | 258,503 | +8.4% | 2.88% | +0.8% |
| AERI | Sell | AERIE PHARMACEUTICALS | $22,036,000 | +21.4% | 368,797 | -1.2% | 2.75% | +17.8% |
| ABT | New | ABBOTT LABS | $21,853,000 | – | 382,909 | +100.0% | 2.73% | – |
| KTWO | Buy | K2M GROUP HOLDINGS | $20,959,000 | +10.2% | 1,164,412 | +29.9% | 2.62% | +6.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $18,277,000 | -5.0% | 82,904 | -15.6% | 2.28% | -7.8% |
| EW | Buy | EDWARDS LIFESCIENCE | $17,819,000 | +23.0% | 158,100 | +19.2% | 2.23% | +19.3% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS | $17,384,000 | +4.9% | 441,768 | -17.2% | 2.17% | +1.7% |
| ABMD | Sell | ABIOMED INC | $15,887,000 | -26.8% | 84,774 | -34.1% | 1.98% | -29.0% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $14,781,000 | +0.4% | 39,316 | +19.4% | 1.85% | -2.6% |
| MDT | Sell | MEDTRONIC PLC | $14,665,000 | -32.9% | 181,610 | -35.4% | 1.83% | -35.0% |
| LLY | New | ELI LILLY & CO | $13,868,000 | – | 164,200 | +100.0% | 1.73% | – |
| CI | Buy | CIGNA CORP | $13,732,000 | +61.0% | 67,615 | +48.2% | 1.72% | +56.3% |
| SRPT | Buy | SAREPTA THERAPEUTICS | $13,298,000 | +324.3% | 238,999 | +245.9% | 1.66% | +311.4% |
| LOXO | Sell | LOXO ONCOLOGY INC | $12,811,000 | -43.3% | 152,185 | -37.9% | 1.60% | -45.0% |
| CLVS | Sell | CLOVIS ONCOLOGY | $12,417,000 | -40.1% | 182,600 | -27.5% | 1.55% | -41.9% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES | $11,041,000 | -22.5% | 142,302 | -38.8% | 1.38% | -24.8% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES | $10,919,000 | +13.6% | 194,800 | +5.2% | 1.36% | +10.2% |
| EXAS | Buy | EXACT SCIENCES CORP | $10,111,000 | +82.5% | 192,450 | +63.7% | 1.26% | +76.9% |
| VRAY | New | VIEWRAY INC | $8,772,000 | – | 947,306 | +100.0% | 1.10% | – |
| ABBV | New | ABBVIE INC | $8,249,000 | – | 85,298 | +100.0% | 1.03% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $7,036,000 | – | 117,815 | +100.0% | 0.88% | – |
| MNTA | Buy | MOMENTA PHARMACEUTICALS | $6,979,000 | +1.3% | 500,298 | +34.3% | 0.87% | -1.8% |
| PRTA | Sell | PROTHENA CORP PLC | $6,901,000 | -45.6% | 184,063 | -6.0% | 0.86% | -47.3% |
| WMGI | Sell | WRIGHT MED GROUP N Vord eur | $6,837,000 | -29.3% | 307,972 | -17.6% | 0.85% | -31.4% |
| PODD | New | INSULET CORP | $6,521,000 | – | 94,509 | +100.0% | 0.82% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $6,216,000 | +87.7% | 242,803 | +53.6% | 0.78% | +82.0% |
| PTCT | Buy | PTC THERAPEUTICS | $6,216,000 | +82.2% | 372,634 | +118.5% | 0.78% | +76.6% |
| MASI | MASIMO CORP | $6,173,000 | -2.0% | 72,800 | 0.0% | 0.77% | -5.0% | |
| MRK | Sell | MERCK & CO INC | $6,105,000 | -70.7% | 108,501 | -66.6% | 0.76% | -71.6% |
| EVH | Sell | EVOLENT HEALTH INC | $6,051,000 | -47.9% | 491,982 | -24.6% | 0.76% | -49.5% |
| IART | Sell | INTEGRA LIFESCIENCE | $5,896,000 | -17.0% | 123,198 | -12.5% | 0.74% | -19.5% |
| HRC | New | HILL-ROM HLDS INC | $5,854,000 | – | 69,450 | +100.0% | 0.73% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS | $5,502,000 | +6.4% | 36,715 | +8.0% | 0.69% | +3.2% |
| ONCE | Sell | SPARK THERAPEUTICS | $4,288,000 | -58.8% | 83,390 | -28.5% | 0.54% | -60.0% |
| ACHC | Sell | ACADIA HEALTHCARE | $4,131,000 | -73.7% | 126,602 | -61.6% | 0.52% | -74.5% |
| MOH | Sell | MOLINA HEALTHCARE | $4,007,000 | -73.6% | 52,260 | -76.3% | 0.50% | -74.3% |
| INCY | Buy | INCYTE CORPORATION | $3,688,000 | -6.4% | 38,945 | +15.4% | 0.46% | -9.1% |
| MDGL | New | MADRIGAL PHARMACEUTICALS | $3,382,000 | – | 36,850 | +100.0% | 0.42% | – |
| TSRO | Sell | TESARO INC | $3,033,000 | -84.3% | 36,600 | -75.6% | 0.38% | -84.8% |
| SAGE | New | SAGE THERAPEUTICS | $2,833,000 | – | 17,200 | +100.0% | 0.35% | – |
| INSM | Buy | INSMED INC | $2,812,000 | +44.4% | 90,199 | +44.6% | 0.35% | +39.8% |
| AGIO | AGIOS PHARMACEUTICALS | $2,733,000 | -14.4% | 47,799 | 0.0% | 0.34% | -17.0% | |
| ARAY | Sell | ACCURAY INC | $2,560,000 | -6.9% | 595,447 | -13.4% | 0.32% | -9.6% |
| SVRA | New | SAVARA INC | $2,374,000 | – | 160,000 | +100.0% | 0.30% | – |
| OBSV | Sell | OBSEVA SA | $2,063,000 | +19.1% | 211,407 | -0.7% | 0.26% | +15.7% |
| INTEC PHARMA LTD JERUSALEM | $1,828,000 | -42.5% | 355,000 | 0.0% | 0.23% | -44.3% | ||
| PTI | New | PROTEOSTASIS THERAPEUTICS | $1,749,000 | – | 300,000 | +100.0% | 0.22% | – |
| SBPH | SPRING BK PHARMACEUTICALS | $1,658,000 | -20.2% | 123,383 | 0.0% | 0.21% | -22.8% | |
| ESPR | New | ESPERION THERAPEUTICS | $1,536,000 | – | 23,333 | +100.0% | 0.19% | – |
| PBYI | New | PUMA BIOTECHNOLOGY | $1,488,000 | – | 15,050 | +100.0% | 0.19% | – |
| DBVT | Buy | DBV TECHNOLOGIESspns ad | $1,483,000 | -33.8% | 60,298 | +14.2% | 0.18% | -36.0% |
| CMTA | Buy | CLEMENTIA PHARMACEUTICALS | $1,429,000 | +179.1% | 75,313 | +148.5% | 0.18% | +171.2% |
| ZLAB | Sell | ZAI LAB LTDadr | $1,053,000 | -85.3% | 49,584 | -81.3% | 0.13% | -85.7% |
| RDY | Sell | DR REDDYS LABS LTDadr | $958,000 | -41.4% | 25,496 | -44.3% | 0.12% | -42.9% |
| SRRA | SIERRA ONCOLOGY INC | $752,000 | +140.3% | 201,660 | 0.0% | 0.09% | +135.0% | |
| TGTX | Exit | TG THERAPEUTICS | $0 | – | -100,366 | -100.0% | -0.15% | – |
| Exit | TRILLIUM THERAPEUTCS | $0 | – | -234,248 | -100.0% | -0.16% | – | |
| ILMN | Exit | ILLUMINA INC | $0 | – | -9,350 | -100.0% | -0.24% | – |
| NXTM | Exit | NXSTAGE MEDICAL | $0 | – | -98,579 | -100.0% | -0.35% | – |
| RARX | Exit | RA PHARMACEUTICALS | $0 | – | -278,082 | -100.0% | -0.52% | – |
| EVHC | Exit | ENVISION HEALTHCARE | $0 | – | -113,600 | -100.0% | -0.66% | – |
| Exit | NEURODERM LTD | $0 | – | -147,756 | -100.0% | -0.74% | – | |
| NUVA | Exit | NUVASIVE INC | $0 | – | -132,290 | -100.0% | -0.94% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -234,900 | -100.0% | -2.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.